Current state and future of 3D bioprinted models for cardio-vascular research and drug development

In the last decade, 3D bioprinting technology has emerged as an innovative tissue engineering approach for regenerative medicine and drug development. This article aims at providing an overview about the most commonly used bioengineered tissues, focusing on 3D bioprinted cardiac cells and how they have been utilized for drug discovery and development. The review describes that, while this field is still developing, cardiovascular research may benefit from laboratory-engineered heart tissues built of specific cell types with precise 3D architecture mimicking the native cardiac microenvironment. It also describes the role played by regulatory agencies and potential commercialization pathways for direct translation from the bench to the bedside of studies using 3D bioprinted cardiac tissues. ©2021 by the authors. This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).

Abstract licence: CC BY

1. 2.

   Hydrogels for Engineering of Perfusable Vascular Networks · 2015

2. 3.

   In Vitro Engineering of Vascularized Tissue Surrogates · 2013

3. 6.

   Increased afterload induces pathological cardiac hypertrophy: a new in vitro model · 2012

4. 18.

   Three-dimensional printing of complex biological structures by freeform reversible embedding of suspended hydrogels · 2015

5. 25.

   Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 · 2017

6. 26.
   Corrected

   Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 · 2016

7. 30.

   Cardiac spheroids as promising in vitro models to study the human heart microenvironment · 2017

8. 40.

   A multi-cellular 3D bioprinting approach for vascularized heart tissue engineering based on HUVECs and iPSC-derived cardiomyocytes · 2018

9. 43.

   3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts · 2019

50 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.